Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection.
about
Autoimmune inflammatory disorders, systemic corticosteroids and pneumocystis pneumonia: a strategy for preventionThe unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature reviewSeverity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomasImmune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.Preventing infective complications in inflammatory bowel disease.Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumoniaImmunosuppression in patients with high-grade gliomas treated with radiation and temozolomidePrevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.Colonization by Pneumocystis jirovecii and its role in disease.The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease.Management of Pneumocystis pneumonia in patients with inflammatory disorders.Unsuspected Pneumocystis pneumonia in an HIV-seronegative patient with untreated lung cancer: circa case report.Spectrum of infection, risk and recommendations for prophylaxis and screening among patients with lymphoproliferative disorders treated with alemtuzumab*.Pneumocystis jiroveci Pneumonia in an Atypical HostPneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital.Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection.Pneumocystis pneumonia in a non-HIV patient on chronic corticosteroid therapy: a question of prophylaxisAudit of pneumocystis pneumonia in patients seen by the Christchurch Hospital rheumatology service over a 5-year period.Genetic variation at the mitochondrial large-subunit rRNA locus of Pneumocystis isolates from simian immunodeficiency virus-infected rhesus macaques.Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons.Bronchoalveolar lavage in immunocompromised patients with haematological malignancy--value of new microbiological methods.Immune Modulation as Adjunctive Therapy for Pneumocystis pneumonia.Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis.Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections.Prophylaxis for Pneumocystis jiroveci pneumonia: is it a necessity in pulmonary patients on high-dose, chronic corticosteroid therapy without AIDS?Pneumocystis Pneumonia and the Rheumatologist: Which Patients Are At Risk and How Can PCP Be Prevented?High Pneumocystis jirovecii colonization rate among haemodialysis patients.Pneumocystis jirovecii colonization among renal transplant recipients.High prevalence of Pneumocystis jirovecii colonization among patients with autoimmune inflammatory diseases and corticosteroid therapy.Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients.Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection.Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review.Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression.Substantial variation in post-engraftment infection prophylaxis and revaccination practice in autologous stem cell transplant patients.Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors.Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxis.Pneumocystis jirovecii pneumonia in HIV-negative patients: a prospective study with focus on immunosuppressive drugs and markers of immune impairment.Pneumocystis pneumonia in solid organ transplantation.
P2860
Q24791788-92EF4EE8-52C2-42CD-BBD8-D6FD8937FFD7Q24809668-215E6D22-4C34-4EFD-BAD9-1F7E2D5ABA80Q26862551-2DF08ADE-4524-4F57-87F1-EF1E6C1B870BQ33680480-DF4907F9-9866-4743-B570-FBA05A2580B6Q34008766-4A7B5EF1-E5C3-4C80-95DC-EB0892540582Q35148566-C7426498-33D2-44B4-914D-F96AF51362ACQ35167257-66823A40-D8D6-412E-B67D-5D59DA9863ABQ35920640-9CAC492D-BA13-465F-8AF7-8FC8213CA111Q35940586-0262BBFC-79D3-4715-AA63-ADADF2313320Q36026672-4BC66273-C84E-49B6-9494-F1B5F486407AQ36162376-77AFD7C7-F436-454D-8601-613A4CCB0BD5Q36285976-243CC506-5650-45A2-A3EC-772577424AB2Q36349776-2EB38C1D-2CF2-4855-B9B0-C86D892783D4Q36399801-56A9C97D-8C7C-41D8-86F0-BBB91407B2B1Q36434896-E3C07630-60BA-41FD-A3B5-0F1DDECF7D3BQ36616349-EA86D22D-F2A6-4627-8BF5-2ED851006A8FQ36642119-7D01FCCD-C5B2-4CAC-BD83-F0D1C0869CE7Q36745959-1F7A5886-4885-4A67-8E1D-381D00FF5BE3Q36828260-4A74125D-B940-4FD2-A362-4299D66E09E7Q37057495-F73F76B6-4D7D-436E-AA21-3F5EAD58CD48Q37469079-A857C302-E738-4F83-84AB-9E12EA53248DQ37865558-54EBDC8B-5933-4B7C-9887-6DBA37F10966Q37929578-2A6A1E7F-DD18-4A83-B48D-6BDD3D18F36FQ38106512-8A4A0B37-5EB9-4E70-95D7-B9F9607290FAQ38235148-A94B64C1-1CB2-4E38-AC0A-C0597C489127Q38378391-A95E2D52-F930-4219-9E8B-1B16CC8C1ED5Q38794907-90AF05B8-8F50-4BA6-A9E8-A573E67B9292Q39012791-FF90643D-E3F0-418D-A8E5-372EB245A63FQ39012798-02A877E6-BA1B-48CD-A7EB-063FD2E389ADQ39012809-31ADDD6A-9965-4086-9AC8-80FC095B6EA7Q39265885-B0ACC4D2-12C9-4531-A29A-9B4FA42D89CAQ39649365-9C258905-E914-49C4-8FA7-CF5B894B89F5Q40046796-BBCEC8F3-3E6D-44D3-BCB8-6BC9FF40EB26Q40100993-38A89B0E-51B5-40E9-950F-CBFA72C66B62Q40396288-1A84BFC2-1F4B-4583-81A3-1BCC314B6839Q40758750-D2862279-8B0E-40E5-9AD6-0140F0C78E5FQ40974744-59EFB574-D724-425D-A73B-73BB9430896FQ42225847-D96D8DD7-6AEB-4CD8-AA08-A74FFBF12DA7Q42231929-590A4C33-5E87-4C7F-B749-EE154BABA6BAQ42272280-0ED99588-DD9C-421A-813F-E2AA81F3CB59
P2860
Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Peripheral blood CD4 + T-lymph ...... atients without HIV infection.
@en
Peripheral blood CD4 + T-lymph ...... atients without HIV infection.
@nl
type
label
Peripheral blood CD4 + T-lymph ...... atients without HIV infection.
@en
Peripheral blood CD4 + T-lymph ...... atients without HIV infection.
@nl
prefLabel
Peripheral blood CD4 + T-lymph ...... atients without HIV infection.
@en
Peripheral blood CD4 + T-lymph ...... atients without HIV infection.
@nl
P2093
P921
P356
P1433
P1476
Peripheral blood CD4 + T-lymph ...... atients without HIV infection.
@en
P2093
Balachandran D
Mansharamani NG
Vernovsky I
P304
P356
10.1378/CHEST.118.3.712
P407
P577
2000-09-01T00:00:00Z